Product/Composition:- | Glycopyrrolate + Formoterol |
---|---|
Strength:- | Glycopyrrolate 9 mcg + Formoterol fumarate 4.8 mcg |
Form:- | Pressurized metered-dose inhaler (pMDI) |
Reference Brands:- | Bevespi Aerosphere(US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Glycopyrrolate + Formoterol is a LAMA/LABA combination used for COPD maintenance treatment. Marketed as Bevespi Aerosphere in the U.S., it offers twice-daily bronchodilation via a metered-dose inhaler, helping improve lung function and reduce breathlessness in COPD patients. It is not intended for acute symptom relief.
Glycopyrrolate + Formoterol is a long-acting bronchodilator combination used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). Glycopyrrolate, a LAMA, and Formoterol, a LABA, work together to relax airway muscles, improve airflow, and reduce symptoms like breathlessness. Marketed as Bevespi Aerosphere in the United States, this combination is delivered via a pressurized metered-dose inhaler (pMDI) and taken twice daily. It is not intended for acute symptom relief but provides long-term control of COPD symptoms. Bevespi Aerosphere helps enhance lung function, reduce exacerbations, and improve the overall quality of life for patients with moderate to severe COPD.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications